Overview

Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a commonly prescribed orally inhaled corticosteroid treatment will induce a clinically meaningful elevation in intraocular pressure, when administered to patients with ocular hypertension (OHT) or open-angle glaucoma (OAG). Based on the response to high-dose corticosteroids, this patient group is more likely than the normal population to demonstrate this adverse effect.
Phase:
Phase 4
Details
Lead Sponsor:
University Health Network, Toronto
Treatments:
Fluticasone
Xhance